Therefore, our results indicated that GSTA2 plays an essential role in metastasis of HCCs, and targeted inhibition of GST2 may be a potential therapeutic strategy for the treatment of HCC. The gene discussed is GSTA2; the disease is hepatocellular carcinoma.